Insider Transactions in Q4 2017 at Bristol Myers Squibb CO (BMY)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Dec 15 2017	Theodore R. Samuels Ii Director	BUY Open market or private purchase	Direct	4,000 +15.38%	$248,000 $62.3 P/Share
Dec 12 2017	Thomas J. Lynch Jr. EVP & Chief Scientific Officer	SELL Open market or private sale	Direct	5,300 -36.43%	$333,900 $63.24 P/Share
Dec 04 2017	Sandra Leung EVP, General Counsel	SELL Open market or private sale	Direct	156,582 -26.79%	$9,864,666 $63.37 P/Share
Dec 04 2017	Sandra Leung EVP, General Counsel	BUY Exercise of conversion of derivative security	Direct	156,582 +21.13%	$3,444,804 $22.14 P/Share
Dec 02 2017	Charles A Bancroft EVP, Head of Integration	SELL Payment of exercise price or tax liability	Direct	2,882 -1.08%	$178,684 $62.47 P/Share
Dec 02 2017	Charles A Bancroft EVP, Head of Integration	BUY Exercise of conversion of derivative security	Direct	6,401 +2.33%	-
Nov 01 2017	John E Elicker EVP, Investor Relations	SELL Payment of exercise price or tax liability	Direct	223 -0.33%	$13,826 $62.16 P/Share
Nov 01 2017	John E Elicker EVP, Investor Relations	BUY Exercise of conversion of derivative security	Direct	494 +0.72%	-

Receive a notification when an Institution or Guru buys or sells BMY shares.

Notify only if

Value

Get notified when an Bristol Myers Squibb CO insider buys or sells BMY shares.

Notify only if

Operation

Value

Type

Receive news related to BRISTOL MYERS SQUIBB CO